Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Progression of disease within 24 months (POD24) in follicular lymphoma in the rituximab era: incidence, clinicopathological risk factors, and outcome in a population-based Danish cohort.
Enemark MH, Hemmingsen JK, Andersen MD, Hybel TE, Bjørn ME, Josefsson PL, Pedersen LM, Juul MB, Pedersen RS, Thorsgaard M, Sillesen IB, Plesner TL, Hamilton-Dutoit SJ, Jensen P, Madsen C, Ludvigsen M. Enemark MH, et al. Among authors: juul mb. Blood Cancer J. 2024 Sep 30;14(1):167. doi: 10.1038/s41408-024-01150-3. Blood Cancer J. 2024. PMID: 39349431 Free PMC article. No abstract available.
Minimal Loss of Lifetime for Patients With Diffuse Large B-Cell Lymphoma in Remission and Event Free 24 Months After Treatment: A Danish Population-Based Study.
Jakobsen LH, Bøgsted M, Brown PN, Arboe B, Jørgensen J, Larsen TS, Juul MB, Schurmann L, Højberg L, Bergmann OJ, Lassen T, Josefsson PL, Jensen P, Johnsen HE, El-Galaly TC. Jakobsen LH, et al. Among authors: juul mb. J Clin Oncol. 2017 Mar;35(7):778-784. doi: 10.1200/JCO.2016.70.0765. Epub 2017 Jan 17. J Clin Oncol. 2017. PMID: 28095160
No differential overall or relative survival effect of rituximab in male and female patients with diffuse large B-cell lymphoma: a Danish population-based study of 3783 patients.
Jakobsen LH, Biccler JL, Brown PN, Jørgensen JM, Josefsson PL, Poulsen CB, Starklint J, Clausen MR, Pedersen PT, Juul MB, Severinsen MT, Bøgsted M, El-Galaly TC. Jakobsen LH, et al. Among authors: juul mb. Leuk Lymphoma. 2019 Nov;60(11):2798-2801. doi: 10.1080/10428194.2019.1602264. Epub 2019 May 6. Leuk Lymphoma. 2019. PMID: 31057011 No abstract available.
A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.
El-Galaly TC, Bilgrau AE, de Nully Brown P, Mylam KJ, Ahmad SA, Pedersen LM, Gang AO, Bentzen HH, Juul MB, Bergmann OJ, Pedersen RS, Nielsen BJ, Johnsen HE, Dybkaer K, Bøgsted M, Hutchings M. El-Galaly TC, et al. Among authors: juul mb. Br J Haematol. 2015 May;169(3):435-44. doi: 10.1111/bjh.13316. Epub 2015 Feb 23. Br J Haematol. 2015. PMID: 25709094 Free article.
Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
Baech J, Hansen SM, Lund PE, Soegaard P, Brown PN, Haaber J, Jørgensen J, Starklint J, Josefsson P, Poulsen CB, Juul MB, Torp-Pedersen C, El-Galaly TC. Baech J, et al. Among authors: juul mb. Br J Haematol. 2018 Dec;183(5):717-726. doi: 10.1111/bjh.15603. Epub 2018 Nov 8. Br J Haematol. 2018. PMID: 30406945 Free article.
Clinical prognostic scores are poor predictors of overall survival in various types of malignant lymphomas.
Biccler JL, El-Galaly TC, Bøgsted M, Jørgensen J, de Nully Brown P, Poulsen CB, Starklint J, Juul MB, Christensen JH, Josefsson P, Dessau A, Jakobsen LH. Biccler JL, et al. Among authors: juul mb. Leuk Lymphoma. 2019 Jun;60(6):1580-1583. doi: 10.1080/10428194.2018.1540044. Epub 2018 Nov 14. Leuk Lymphoma. 2019. PMID: 30424711 No abstract available.
Treatment strategies and outcomes in diffuse large B-cell lymphoma among 1011 patients aged 75 years or older: A Danish population-based cohort study.
Juul MB, Jensen PH, Engberg H, Wehberg S, Dessau-Arp A, Haziri D, Kristensen HB, Baech J, Schurmann L, Clausen MR, Valentin R, Knudsen LM, Munksgaard L, El-Galaly TC, Frederiksen H, Larsen TS. Juul MB, et al. Eur J Cancer. 2018 Aug;99:86-96. doi: 10.1016/j.ejca.2018.05.006. Epub 2018 Jun 20. Eur J Cancer. 2018. PMID: 29935491
The number of extranodal sites assessed by PET/CT scan is a powerful predictor of CNS relapse for patients with diffuse large B-cell lymphoma: An international multicenter study of 1532 patients treated with chemoimmunotherapy.
El-Galaly TC, Villa D, Michaelsen TY, Hutchings M, Mikhaeel NG, Savage KJ, Sehn LH, Barrington S, Hansen JW, Smith D, Rady K, Mylam KJ, Larsen TS, Holmberg S, Juul MB, Cordua S, Clausen MR, Jensen KB, Johnsen HE, Seymour JF, Connors JM, de Nully Brown P, Bøgsted M, Cheah CY. El-Galaly TC, et al. Among authors: juul mb. Eur J Cancer. 2017 Apr;75:195-203. doi: 10.1016/j.ejca.2016.12.029. Epub 2017 Feb 23. Eur J Cancer. 2017. PMID: 28237865 Free article.
15 results